Qube Research & Technologies Ltd
Position in ABOS — Acumen Pharmaceuticals, Inc.
CIK 1729829
LONDON, X0
Position in ABOS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$103,099
-$181,016 QoQ
Shares Held
38,614
-67.9% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 96 holders
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,042,063 across 169 Biotechnology names. ABOS ranks #144 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in ABOS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,099 | 38,614 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $284,115 | 120,388 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $101,248 | 47,985 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $56,226 | 32,881 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $66,768 | 57,559 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,348 | 22,135 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $117,512 | 68,321 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $205,100 | 82,702 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $183,602 | 75,869 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $678,731 | 167,588 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $340,323 | 88,626 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $108,368 | 26,113 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $180,203 | 44,385 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $288,160 | 53,363 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $167,631 | 16,713 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $104,617 | 22,259 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||